Cardiac AI Monitoring and Diagnostics Market Report with Forecast 2026 to 2035
Share With :
Global Cardiac AI Monitoring and Diagnostics Market Size is valued at USD 1.82 Bn in 2025 and is predicted to reach USD 19.78 Bn by the year 2035 at an 27.0% CAGR during the forecast period for 2026 to 2035.
Cardiac AI Monitoring and Diagnostics Market Size, Share & Trends Analysis Report By Product (Software and Hardware), By Type (Imaging, ECG-based, Cardiac Monitoring, and Others), By Application, By End Users, Region, And Segment Forecasts, 2026 to 2035.
Artificial intelligence technology helps to improve diagnosis, treatment planning, and patient outcomes. AI can be used for many applications, including image analysis for disease detection & diagnosis, predictive analytics for risk evaluation and earlier intervention, and personalized treatments. In addition, technology can simplify, facilitate and enhance clinical decision-making via real-time data study. The use of AI in cardiology is still in its early stages of development, but the potential benefits are enormous, including improvements in accuracy, efficiency, and patient outcomes.
The global Cardiac AI Monitoring and Diagnostics Market is prominently driven by the rising incidence of cardiovascular disorders and the growing demand for effective & cutting-edge devices. Cardiovascular diseases can be effectively treated if noticed early. Thus, increasing demand for early detection & diagnosis of CVDs is likely to propel business growth in the upcoming years. Moreover, several software companies have adopted strategies such as partnerships, collaborations, acquisitions, funding, and others to improve their overall position in the market.
The Cardiac AI Monitoring and Diagnostics Market is segmented based on product, type, application, and end users. The product segment comprises software and hardware. By type, the market is categorized into imaging, ECG-based, cardiac monitoring, and others. By application, the market has been classified into cardiac arrhythmias, cardiac stroke, ischemic heart disease/CAD, and others. The end users segment is divided into hospitals, diagnostic centers, and other end users.
By type, the ECG-based devices segment is expected to lead the market during the forecast period. ECG-based devices are used to identify various cardiac diseases and help in selecting the best treatment. The ECG (electrocardiogram) device records heartbeats using electric signals and is a non-invasive, painless procedure.
By application, the Ischemic Heart Disease/ CAD segment dominated the Cardiac AI Monitoring and Diagnostics Market in 2022. Coronary artery disease (CAD) is one of the most common types of heart disease and affects a vast number of individuals worldwide. The increasing cases of CAD and cardiac stroke are likely to improve the incorporation of AI in monitoring, diagnosing, and treating coronary artery diseases, which is predicted to enhance market growth.
Based on end-users, the hospital segment is expected to witness the fastest expansion over the projected period. Factors including the rising adoption of Al-based cardiovascular diagnostic & monitoring devices, improved healthcare infrastructure, and the development of favourable reimbursement policies are contributing to the growth of the hospital segment.
In 2022, North America accounted for the highest share of the Cardiac AI Monitoring and Diagnostics Market. The factors such as well-developed healthcare infrastructure, rising adoption of Al-based systems, and the increasing CVD cases in the US are driving the market in North America. In addition, Asia Pacific, due to its improving healthcare facilities and fast adoption of advanced cardiovascular diagnostic & monitoring devices, has recorded an increase in the demand for Cardiac AI Monitoring and Diagnostics Market.
| Report Attribute | Specifications |
| Market Size Value In 2025 | USD 1.82 Bn |
| Revenue Forecast In 2035 | USD 19.78 Bn |
| Growth Rate CAGR | CAGR of 27.0% from 2026 to 2035 |
| Quantitative Units | Representation of revenue in US$ Bn and CAGR from 2026 to 2035 |
| Historic Year | 2022 to 2025 |
| Forecast Year | 2026-2035 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Product, By Type, By Application, By End Users |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | Aidoc, Tempus Labs, Canon, Inc., Circle Cardiovascular Imaging Inc., General Electric Company, HeartFlow, Inc., iRhythm Technologies, Inc., Koninklijke Philips N.V., Siemens Healthineers AG, Viz.ai, Ultromics, Ltd., Cathworks, Boston Scientific Corporation, and others. |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Cardiac AI Monitoring and Diagnostics Market By Product-
Cardiac AI Monitoring and Diagnostics Market By Type-
Cardiac AI Monitoring and Diagnostics Market By Application-
Cardiac AI Monitoring and Diagnostics Market By End Users-
Cardiac AI Monitoring and Diagnostics Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.